DK139191D0 - Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein - Google Patents
Anvendelse af et n-acylcystein og middel indeholdende et n-acylcysteinInfo
- Publication number
- DK139191D0 DK139191D0 DK911391A DK139191A DK139191D0 DK 139191 D0 DK139191 D0 DK 139191D0 DK 911391 A DK911391 A DK 911391A DK 139191 A DK139191 A DK 139191A DK 139191 D0 DK139191 D0 DK 139191D0
- Authority
- DK
- Denmark
- Prior art keywords
- cystein
- acyl
- medicinal containing
- medicinal
- acyl cystein
- Prior art date
Links
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30239689A | 1989-01-26 | 1989-01-26 | |
PCT/US1990/000363 WO1990008540A1 (en) | 1989-01-26 | 1990-01-24 | Treatment of disease associated with hiv-infections |
Publications (2)
Publication Number | Publication Date |
---|---|
DK139191A DK139191A (da) | 1991-07-25 |
DK139191D0 true DK139191D0 (da) | 1991-07-25 |
Family
ID=23167578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK911391A DK139191D0 (da) | 1989-01-26 | 1991-07-25 | Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein |
Country Status (25)
Country | Link |
---|---|
US (1) | US5607974A (ja) |
JP (1) | JPH04504570A (ja) |
KR (1) | KR940002820B1 (ja) |
AU (1) | AU639686B2 (ja) |
BE (1) | BE1004168A3 (ja) |
CA (3) | CA1339256C (ja) |
CH (1) | CH683499A5 (ja) |
DE (1) | DE4090165T (ja) |
DK (1) | DK139191D0 (ja) |
FR (1) | FR2643557B1 (ja) |
GB (1) | GB2243296B (ja) |
GR (1) | GR900100048A (ja) |
IE (1) | IE62795B1 (ja) |
IL (1) | IL93162A (ja) |
IT (1) | IT1237999B (ja) |
LU (1) | LU87977A1 (ja) |
MA (1) | MA21739A1 (ja) |
MX (1) | MX173567B (ja) |
NL (1) | NL9020094A (ja) |
OA (1) | OA09503A (ja) |
PT (1) | PT92949B (ja) |
SE (1) | SE9101815D0 (ja) |
TN (1) | TNSN90009A1 (ja) |
WO (1) | WO1990008540A1 (ja) |
ZA (1) | ZA90245B (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT100914A (pt) * | 1991-09-30 | 1993-10-29 | Jess G Thoene | Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv |
US5554655A (en) * | 1991-09-30 | 1996-09-10 | Jess G. Thoene | Method of treating HIV infection |
EP0600462A1 (en) * | 1992-12-01 | 1994-06-08 | Nippon Flour Mills Co., Ltd. | Reverse transcriptase inhibitors and antiviral agents |
AU6060694A (en) * | 1993-05-10 | 1994-11-17 | Transcend Therapeutics, Inc | Method for treating acquired immune deficiency syndrome |
DE4325547C2 (de) * | 1993-07-29 | 1997-11-27 | Max Planck Gesellschaft | Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen |
US5725870A (en) * | 1993-10-15 | 1998-03-10 | Thoene; Jess G. | Methods, composites and articles for contraception |
AU7931094A (en) * | 1993-10-15 | 1995-05-04 | Jess G. Thoene | Prevention of hiv infection |
US5786152A (en) * | 1996-04-26 | 1998-07-28 | Amgen Inc. | Methods of inhibiting syp binding to a CTLA-4 receptor |
HUP9602024A3 (en) * | 1996-07-25 | 1999-05-28 | Toth Sandor | Pharmaceutical composition containing aminoacid for external use |
TW517089B (en) * | 1996-09-03 | 2003-01-11 | Res Dev Foundation | Assessment of intracellular cysteine and glutathione concentrations |
CA2277911C (en) * | 1997-01-13 | 2010-09-14 | Emory University | Compounds and their combinations for the treatment of influenza infection |
US6331610B1 (en) * | 1997-04-25 | 2001-12-18 | Metatron, Inc. | Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin |
US6020205A (en) * | 1998-04-10 | 2000-02-01 | Immunosciences Lab, Inc. | Determination of intracellular antioxidant levels |
US6251868B1 (en) * | 1998-04-30 | 2001-06-26 | Teijin Limited | Method for treating a human immunodeficiency virus infection |
US6566401B2 (en) * | 2001-03-30 | 2003-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
US6355682B1 (en) * | 2001-05-11 | 2002-03-12 | Assa Weinberg | Treatment of acute renal failure by administration of N-acetylcysteine |
ITMI20011863A1 (it) * | 2001-09-05 | 2003-03-05 | Zambon Spa | Associazione di farmaci contro il virus dell'influenza |
US20050070607A1 (en) * | 2003-08-19 | 2005-03-31 | James Andrus | N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions |
EP2397189B1 (en) | 2003-11-14 | 2015-03-18 | Brigham and Women's Hospital, Inc. | Methods of modulating immunity |
ITMI20032528A1 (it) * | 2003-12-19 | 2005-06-20 | Francesco Santangelo | Uso di cistina o di cisteina per la prevenzione e il |
US20070053970A1 (en) * | 2005-05-25 | 2007-03-08 | Guilford F T | Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4148885A (en) * | 1973-09-25 | 1979-04-10 | Institut Merieux | Immunostimulant medicine |
FR2408387A2 (fr) * | 1975-06-30 | 1979-06-08 | Oreal | Compositions a base de dispersions aqueuses de spherules lipidiques |
US4440788A (en) * | 1980-05-13 | 1984-04-03 | Mitsubishi Chemical Industries, Limited | Cysteine derivatives |
US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
US4665082A (en) * | 1981-02-11 | 1987-05-12 | Cornell Research Foundation | Cysteine delivery system |
US4438124A (en) * | 1981-02-11 | 1984-03-20 | Cornell Research Foundation, Inc. | Cysteine delivery system |
US4647571A (en) * | 1981-02-11 | 1987-03-03 | Cornell Research Foundation | Cysteine delivery composition |
US4434158A (en) * | 1981-02-11 | 1984-02-28 | Cornell Research Foundation | Cysteine delivery system |
US4879370A (en) * | 1983-12-02 | 1989-11-07 | Cornell Research Foundation, Inc. | Glutathione delivery system |
US4767785A (en) * | 1984-01-18 | 1988-08-30 | Michael Georgieff | Hypocaloric preparation and intravenous method for hypocaloric treatment of patients |
US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
EP0158487B1 (en) * | 1984-04-09 | 1991-08-28 | Takeda Chemical Industries, Ltd. | Stable composition of interleukin-2 |
US4789633A (en) * | 1984-04-19 | 1988-12-06 | University Of Tennessee Research Corporation | Fused liposome and acid induced method for liposome fusion |
US4710489A (en) * | 1985-04-22 | 1987-12-01 | Cornell Research Foundation, Inc. | Glutathione delivery system |
US4758551A (en) * | 1986-07-08 | 1988-07-19 | Cornell Research Foundation, Inc. | Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types |
DE3707127C2 (de) * | 1987-03-05 | 1996-06-20 | Zambon Spa | Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen |
DE3812008A1 (de) * | 1987-04-10 | 1988-10-20 | Pfrimmer Pharma | Verwendung von l-(-)-thiazolidin-4-carbonsaeure als cysteinquelle bei gestoerter cysteinsynthese |
US4895716A (en) * | 1987-06-09 | 1990-01-23 | Biogen, Inc. | Stabilized formulations of gamma interferons |
DE3906671A1 (de) * | 1989-03-02 | 1990-09-06 | Wulf Prof Dr Droege | Orales, magenvertraegliches n-acetylcysteinpraeparat hoher dosierung |
-
1989
- 1989-09-21 CA CA000612240A patent/CA1339256C/en not_active Expired - Lifetime
- 1989-09-21 CA CA000612229A patent/CA1339070C/en not_active Expired - Lifetime
-
1990
- 1990-01-08 IE IE7390A patent/IE62795B1/en not_active IP Right Cessation
- 1990-01-12 ZA ZA90245A patent/ZA90245B/xx unknown
- 1990-01-22 MX MX019199A patent/MX173567B/es unknown
- 1990-01-23 CH CH201/90A patent/CH683499A5/it not_active IP Right Cessation
- 1990-01-24 PT PT92949A patent/PT92949B/pt not_active IP Right Cessation
- 1990-01-24 IL IL9316290A patent/IL93162A/en not_active IP Right Cessation
- 1990-01-24 TN TNTNSN90009A patent/TNSN90009A1/fr unknown
- 1990-01-24 WO PCT/US1990/000363 patent/WO1990008540A1/en not_active Application Discontinuation
- 1990-01-24 AU AU49694/90A patent/AU639686B2/en not_active Ceased
- 1990-01-24 JP JP2502885A patent/JPH04504570A/ja active Pending
- 1990-01-24 KR KR1019900702099A patent/KR940002820B1/ko not_active IP Right Cessation
- 1990-01-24 DE DE19904090165 patent/DE4090165T/de not_active Ceased
- 1990-01-24 NL NL9020094A patent/NL9020094A/nl not_active Application Discontinuation
- 1990-01-24 CA CA002045180A patent/CA2045180A1/en not_active Abandoned
- 1990-01-24 IT IT01914190A patent/IT1237999B/it active IP Right Grant
- 1990-01-25 MA MA22001A patent/MA21739A1/fr unknown
- 1990-01-25 FR FR9000839A patent/FR2643557B1/fr not_active Expired - Fee Related
- 1990-01-26 GR GR900100048A patent/GR900100048A/el unknown
- 1990-01-26 BE BE9000099A patent/BE1004168A3/fr not_active IP Right Cessation
-
1991
- 1991-06-10 GB GB9112420A patent/GB2243296B/en not_active Expired - Fee Related
- 1991-06-13 SE SE9101815A patent/SE9101815D0/xx not_active Application Discontinuation
- 1991-06-21 OA OA60026A patent/OA09503A/xx unknown
- 1991-07-17 LU LU87977A patent/LU87977A1/xx unknown
- 1991-07-25 DK DK911391A patent/DK139191D0/da not_active Application Discontinuation
-
1994
- 1994-01-10 US US08/180,778 patent/US5607974A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK139191D0 (da) | Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein | |
DK33287A (da) | Imidazolanaloge af mevalonolacton og derivater deraf | |
DK350489D0 (da) | Elektrisk resonator og anvendelse af resonator | |
DK0445255T3 (da) | Behandling af tilstande og sygdom | |
DK170187A (da) | Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette | |
DK335389A (da) | Komposit-agrotekstil og anvendelser af dette | |
KR890700208A (ko) | 카메라 및 다른 기구 지지대 | |
DK433786A (da) | Farmaceutiske praeparater og medicinske anvendelser af dioxopiperidinderivater | |
DK0517761T3 (da) | Lipaseholdig flydende pre-spotter og anvendelsen af en sådan pre-spotter | |
DK323986D0 (da) | Diazinylpiperidinderivater af cykliske amider og imider | |
DK141090D0 (da) | Fremstilling af human prourokinase | |
DK102389D0 (da) | Anvendelse af interleukin | |
DK104389A (da) | Anvendelse af imidazolderivater | |
DK240689A (da) | Tinholdige copolymerisater og anvendelse deraf | |
DK641289A (da) | Ophthalmologisk praeparat indeholdende et angiotensin-konverterende anzym og carboanhydrase | |
DK127187D0 (da) | Farmaceutisk kombination af t-pa og oxypurinol | |
DK299889A (da) | Kloning og ekspression af human vaevsfaktor | |
DK75691A (da) | Ny farmaceutisk anvendelse af fusidin og derivater deraf | |
DK423789D0 (da) | Ekspression og anvendelse af et humant plasmaglycoprotein | |
DK394488D0 (da) | 5-pyrimidincarboxamider og behandling af leukaemi dermed | |
DK394388D0 (da) | 5-pyrimidincarboxamider og behandling af leukaemi dermed | |
BR8903829A (pt) | Purificacao de telomeros preparados de cloro-tri-fluor-etileno e tri-cloro-tri-fluor-etano | |
DK363786A (da) | Hydroquinoliner og anvendelse deraf | |
DK573487D0 (da) | Cyklodextrinclathrater af carbacyklinderivater og anvendelse deraf som laegemiddel | |
DK29687D0 (da) | Antihypoxisk medikament med cerebro og hepatobeskyttende virkning og anvendelse af samme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |